OOIR: Observatory of International Research

Papers

(The H4-Index of Pediatric Blood & Cancer is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Comparing Absolute Neutrophil Counts of Children With Sickle Cell Disease With and Without the Duffy Null Phenotype	91
Brochure intervention to manage bothersome taste changes in pediatric patients receiving cancer therapy	52
Palliative care and suicidality: Complicated conversations at two ends of the spectrum	50
	48
Fatal brainstem injury following proton radiation in a patient with medulloblastoma and a germline variant in RNF213	45
How we approach complex vascular anomalies and overgrowth syndromes	43
The Ukrainian children emergency: How the Pediatric Oncology Unit of Turin supports cancer patients and their families who have escaped war	42
Emicizumab in Previously Untreated Patients and Minimally Treated Patients With Hemophilia A: A Comparative Study Between Two International Cohorts	41
Urgent Chemotherapy for Swift Symptom Relief in Patients With Medulloblastoma	38
Response assessment by positron emission tomography‐computed tomography as compared with contrast‐enhanced computed tomography in childhood Hodgkin lymphoma can reduce the need for radiotherapy in low	36
Efficacy of dual‐task training on stability and function in children with ataxia after medulloblastoma resection: A randomized controlled trial	35
Refractory thrombocytopenia and myelofibrosis in a novel KDSR mutation: Case report and literature review	31
Prevalence of Duffy null and its impact on hydroxyurea in young children with sickle cell disease in the United States	31
Neonatal giant axillary hemangioma with subclavian arteriovenous fistula and heart failure	29
Pediatric erythroblastic transformation of JAK2‐mutated prefibrotic primary myelofibrosis with concurrent PHF6 mutations	29
ALK inhibition as a salvage therapy for a relapsed unclassifiable sarcomatous CNS tumor with EML4/ALK fusion in an infant	27
The role of neoadjuvant chemotherapy in the management of metastatic central nervous system germinoma: A meta‐analysis	26
Bloodletting as Medical Child Abuse Revealed by Lack of Iron Accumulation Despite Multiple Erythrocyte Transfusions	25
Image‐Guided Biopsy for the Diagnosis and Molecular Profiling of Hepatoblastoma	25
Impact of Food Insecurity on Malnutrition Treatment Response in Nigerian Children With Sickle Cell Anemia and Severe Acute Malnutrition	25
Bone mineral density in primarily preadolescent children with hemoglobin E/β‐thalassemia with different severities and transfusion requirements	24
Luspatercept for non‐deletional hemoglobin H disease	23
A three‐year‐old with central nervous system graft versus host disease: A rare cause of posthematopoietic stem cell transplant encephalopathy	23
Strategies for the Treatment of Desmoplastic Small Round Cell Tumor: A Case Series	23
Rapid symptomatic improvement in two patients with ganglioglioma after restarting BRAF inhibitor therapy	23

A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors